LYEL Lyell Immunopharma, Inc. Common Stock PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

Lyell Immunopharma (LYEL) Stock: Buy, Sell, or Hold?

$16.86
+0.11 (+0.66%) β–²
5d: +9.27% 30d: +124.5% 90d: +22.71%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (33%)
Quality Score
33/100
Position
EXTENDED
30-Day Fair Range
$7.86 – $13.51
Position: EXTENDED
Forward P/E & Valuation
-2.7x
Next 12M consensus est.
Wall Street Target
$38.38
+127.6% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$10.56 / $17.61
Trend: Downtrend
πŸ’‘Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR BETTER ENTRY: LYEL is 24.8% above its trading range ($13.51). While momentum could continue, risk/reward favors waiting for a pullback.

Get Alerted When LYEL Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: LYEL is currently trading at $16.86, which is considered extended relative to its 30-day fair value range of $7.86 to $13.51.

Technical Outlook: Technically, LYEL is in a downtrend. Immediate support is located at $10.56, while resistance sits at $17.61.

Market Sentiment: LYEL scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $38.38 (+127.6%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $7.86 - $13.51
Company Quality Score 33/100 (SELL)
Volume Confirmation HIGH
Confidence Score 33.3%

Trading Range & Key Levels

30-Day Trading Range $7.86 - $13.51
Current vs Trading Range EXTENDED
Expected Move (7 Days) Β±$1.43 (8.5%)
Support Level $10.56
Resistance Level $17.61
Current Trend Downtrend
Technical data as of Nov 11, 2026

Quantitative Signal Breakdown

  • BEARISH: Price significantly overextended (+24.8% above its trading range)
  • BULLISH: Options cheap (IV 0th percentile)
  • BEARISH: Weak technical setup (15/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 127.6% below Wall St target ($38.38)
  • WARNING: Composite score 33/100 in the bottom quintile β€” this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -2.67
Wall Street Target $38.38 (+127.6%)
Revenue Growth (YoY) -80.0%
Share LYEL Analysis

Share this live LYEL analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (LYEL)

Bullish 1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 4, 2026
Daily AI digest
AI Retail Discussion Summary: StockTwits shows bullish sentiment towards $LYEL with the message 'LYEL Flowing' being shared by a bullish trader with 11746 followers.
Key Retail Themes: bullish sentiment
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 9:08 PM ET
Data refreshes hourly during market hours. Next update: 10:08 PM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for LYEL.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
VRTX
Vertex Pharmaceuticals I…
STRONG BUY
32 analysts
$592 44 HOLD
ALNY
Alnylam Pharmaceuticals …
STRONG BUY
30 analysts
$302 55 HOLD
ONC
BeOne Medicines AG
STRONG BUY
27 analysts
$438 35 SELL
TVTX
Travere Therapeutics Inc
STRONG BUY
15 analysts
$75 66 BUY
ASND
Ascendis Pharma AS
STRONG BUY
21 analysts
$304 34 SELL

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive LYEL Research Pages
LYEL Technical Chart LYEL Price Prediction LYEL Intrinsic Value DCF LYEL Earnings Date LYEL Investment Advisor LYEL Fair Price Analyzer LYEL Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals